跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Empazox 25 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Empazox 25
Approved
STANDARD
Empazox 25
Annora Pharma Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
25db59dc872797df
Company
Annora Pharma Private Limited
Type
Standard
Approval Details
Approval Id
25db59dc872797df
Drug Approval Philippines Name
Empazox 25
Product Name
Empazox 25
Registration Number
DRP-15760
Brand Name
Empazox 25
Generic Name
Empagliflozin
Dosage Form
Film-Coated Tablet
Dosage Strength
25 mg
Manufacturer
Annora Pharma Private Limited
Importer
Camber Pharmaceuticals, Inc.
Distributor
Camber Pharmaceuticals, Inc.
Company Detail Path
/organization/annora-pharma-private-limited
Importer Detail Path
/organization/camber-pharmaceuticals-inc
Distributor Detail Path
/organization/camber-pharmaceuticals-inc
Issuance Date
11 September 2024
Expiry Date
11 September 2029
Pharmacologic Category
Blood Glucose Lowering Drug (Sodium-Glucose Co- Transporter 2 [SGLT2] Inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
25db59dc872797df
Type
Standard
Back to Philippines FDA Approvals